Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ProMIS Neurosciences Logo
ProMIS Neurosciences Growth Score
50
CB Rank
84207
Heat Score
51
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada1-10 promisneurosciences.com
Biotechnology
Health Diagnostics
Medical
Neuroscience
Therapeutics
Overview

ProMIS Neurosciences
Total Funding
obfuscation
Growth Score
50
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score50
-27 pts
in past quarter
Heat Score 51
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ProMIS Neurosciences

CB Rank
84207
ProMIS Neurosciences develops therapeutic products and diagnostic devices targeting misfolded protein diseases.
Founded
obfuscation
PublicPost-IPO Equity Toronto, Ontario, Canada1-10 promisneurosciences.com
Biotechnology
Health Diagnostics
Medical
Neuroscience
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name ProMIS Neurosciences, Inc.
Operating Status Active
Stock Symbol  NASDAQ:PMN
Company Type For Profit
Founders  Eugene Williams, Neil Cashman
About the Company

ProMIS Neurosciences is a development-stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and effective treatment of neurodegenerative diseases, in particular, Alzheimer’s disease (AD) and amyotrophic lateral sclerosis (ALS).

It was founded in 2004 and headquartered in Toronto,

Canada.

Phone Number (416) 847-6898
Contact Email kevin@promisneurosciences.com
Predictions & Insights

Growth Insight

See this Growth Insight
ProMIS Neurosciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

EpiSelect™
A computational target discovery engine that predicts and identifies disease-specific epitopes on toxic misfolded proteins linked to neurodegenerative diseases.
PMN310
A monoclonal antibody therapy candidate targeting toxic misfolded amyloid-beta oligomers in early Alzheimer's disease.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 21
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 21
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity
obfuscation
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
7
obfuscation
Ally Bridge Group, Janus Henderson InvestorsPost-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Woodline Partners Logo
Woodline Partners
—
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
—
Woodline Partners Logo
Woodline Partners
—
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
—
Woodline Partners Logo
Woodline Partners
—
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
—
Woodline Partners Logo
Woodline Partners
—
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
—
Woodline Partners Logo
Woodline Partners
—
Post-IPO Equity - ProMIS Neurosciences Logo
Post-IPO Equity - ProMIS Neurosciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 6 Board Members and Advisors 5 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jul 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•May 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

942
98.32%
 in past month

Interest Signals

TopicSurge Score
Google (GOOG) Logo
Google (GOOG)
80
Social Security Logo
Social Security
66

Actively Used Products

21ProMIS Neurosciences uses 21 technology products and services including HTML5, GoDaddy Premium DNS, and  Microsoft Outlook, according to G2 Stack.

Active Website Tech Count

2ProMIS Neurosciences is actively using 2 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  ATT.

Total IP

20The intellectual property of ProMIS Neurosciences includes 20 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ProMIS Neurosciences's headquarters? ProMIS Neurosciences is located in Toronto, Ontario, Canada.Who invested in ProMIS Neurosciences? ProMIS Neurosciences has 10 investors including Woodline Partners and  Janus Henderson Investors.When was the last funding round for ProMIS Neurosciences? ProMIS Neurosciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are ProMIS Neurosciences's competitors? Alternatives and possible competitors to ProMIS Neurosciences may include BioArctic AB, Coave Therapeutics, and  Aliada Therapeutics.How much funding has ProMIS Neurosciences raised to date? ProMIS Neurosciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d42803 1)
|